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Introduction and objectives Recently published NICE guidance has significantly expanded 
the approach to adult tuberculosis (TB) contact screening by recommending tuberculin skin 
testing (TST) for pulmonary and laryngeal contacts only, increasing the age threshold for 
screening and treatment to 65 years and defining a positive TST as induration ≥5 mm, 
regardless of BCG vaccination status. Interferon Gamma Release Assay (IGRA) is 
recommended only in situations where more evidence of infection is needed. 
Our institution has previously adopted an approach comprising a chest radiograph, TST and 
IGRA. 
The aim of our study was to evaluate the impact of NICE guidance on screening outcomes 
and resource capacity by applying the criteria to a well-defined historic cohort of TB 
contacts. 
Methods This was a retrospective, observational study carried out at a central London 
teaching hospital. The study population comprised 593 consecutive, adult TB contacts 
screened between 1/1/2008 and 31/12/2010. Data was collected through a retrospective 
review of TST and IGRA tests. 
Results Of the 593 contacts screened, 358 pulmonary contacts had TST and IGRA results. 
56% had a TST ≥5 mm, regardless of BCG status, qualifying them for treatment as per the 
new NICE guidance. Of these, 61% were IGRA negative (discordant) and may therefore 
include false positive diagnoses, resulting in the potential for over treatment. In those with 
TST 5–14 mm, discordance rises to 84%. Conversely, 6% of those with TST < 5 mm are 
IGRA positive representing potentially missed cases. 
16% of screened individuals were contacts of extra pulmonary TB. Not screening this group 
would reduce the demand for outpatient appointments by 151* in our cohort. In contrast, 
testing contacts > 35 years would require capacity for an additional 165* appointments. 
Furthermore, there were 162 additional LTBI cases in comparison to previous guidance 
requiring an additional 648* appointments. 72% of this group were IGRA negative. 
(*Approximate) 
Conclusions Our results show the revised guidance will require increased resource 
capacity largely due to more patients being classified as having latent TB. In addition to 
workforce planning to meet these demands, further debate is needed to decide if this new 
approach truly reduces the incidence of active TB or results in unnecessary treatment. 
 
